Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin (Q46411318)

22 December 2017

title

Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin (English)

1 reference

22 December 2017

1 reference

1 reference

Paul R Lee

1

1 reference

22 December 2017

Dana L Brady

2

1 reference

22 December 2017

Robert A Shapiro

3

1 reference

22 December 2017

Daniel M Dorsa

4

1 reference

22 December 2017

James I Koenig

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

22 December 2017

number of pages

12

1 reference

inferred from page(s)

published in

Neuropsychopharmacology

1 reference

22 December 2017

volume

30

1 reference

22 December 2017

issue

10

1 reference

22 December 2017

page(s)

1883-1894

1 reference

22 December 2017

A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Low and infrequent expression of nitric oxide synthase/NADPH-diaphorase in neurons of the human supraoptic nucleus: a histochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Sensorimotor gating and schizophrenia. Human and animal model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Vasopressin (DDAVP) therapy in chronic schizophrenia: effects on negative symptoms and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Structural evaluation of the prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

The effects of atypical antipsychotic medications on psychosocial outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

The neuroendocrine basis of social recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Mesoprefrontal dopamine neurons and schizophrenia: role of developmental abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Naturally occurring differences in maternal care are associated with the expression of oxytocin and vasopressin (V1a) receptors: gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Neuropeptides and the evolution of social behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Corticosterone alters N-methyl-D-aspartate receptor subunit mRNA expression before puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

To model a psychiatric disorder in animals: schizophrenia as a reality test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Expanded characterization of the social interaction abnormalities in mice lacking Dvl1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

An anxiolytic action of oxytocin is enhanced by estrogen in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Distribution of messenger RNA for the vasopressin V1a receptor in the CNS of male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

D-serine added to antipsychotics for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Oxytocin may mediate the benefits of positive social interaction and emotions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Enhanced social interactions in rats following chronic, centrally infused oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits.

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Treatment of schizophrenia with a vasopressin analogue

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Cerebrospinal fluid neurophysins in affective illness and in schizophrenia

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge.

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Behavioral effects of chronic phencyclidine administration in rats

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

N-methyl-D-aspartic acid stimulation of vasopressin release: role in osmotic regulation and modulation by gonadal steroids

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300722

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300722

1 reference

22 December 2017

1 reference

22 December 2017